Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00756678 · ClinicalTrials.gov registry record · Phase 4
Efficacy and Acceptability of Two Lubricant Eye Drops
A Phase 4 study, sponsored by Allergan.
- Completed
- Registry status
- Phase 4
- Development phase
- 51
- Enrollment target
NCT00756678 is a Phase 4 study that has completed, run by Allergan. The registered enrollment target is 51 participants.
The verdict
NCT00756678, a Phase 4 study, has completed, sponsored by Allergan.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 51 participants
- Enrollment target
Study Summary
Efficacy and acceptability of two new artificial tears following two weeks of treatment in patients with dry eye. Patients will be randomized to 1 of 2 treatments for 7 days then crossover to the alternate treatment for 7 days.
Interventions
- DRUG Lubricant Eye Drops (Optive™)
- DRUG Lubricating Eye Drops (blink® Tears)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 51 participants |
| Start Date | 2008-09 |
| Est. Completion | 2009-08 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00756678
The ClinicalTrials.gov registry entry for NCT00756678 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 51 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Allergan, which has 314 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Lubricant Eye Drops (Optive™) is the first listed.
NCT00756678 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00756678 about?
NCT00756678 is a clinical study titled "Efficacy and Acceptability of Two Lubricant Eye Drops". Efficacy and acceptability of two new artificial tears following two weeks of treatment in patients with dry eye. Patients will be randomized to 1 of 2 treatments for 7 days then crossover to the alternate treatment for 7 days.
What is the current status of trial NCT00756678?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 51 participants. The study started on 2008-09. Estimated completion is 2009-08.
What interventions are being tested in trial NCT00756678?
The interventions under investigation include: Lubricant Eye Drops (Optive™) (DRUG), Lubricating Eye Drops (blink® Tears) (DRUG).
Who is sponsoring clinical trial NCT00756678?
This trial is sponsored by Allergan, which has 314 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.